![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunotherapies inducing immunogenic cell death in cancer: insight of the innate immune system
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodrı́guez-Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Kenny Misael Calvillo‐Rodríguez, Helen Yarimet Lorenzo-Anota, Cristina Rodrı́guez-Padilla, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Showing 17 citing articles:
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 6
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 6
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Engineering a Novel T‐Cell Epitope‐Based Vaccine Targeting PRAME in Cancer Immunotherapy
Zeynab Bayat, Zahra Majidi, Amir Taherkhani, et al.
Peptide Science (2025) Vol. 117, Iss. 1
Closed Access
Zeynab Bayat, Zahra Majidi, Amir Taherkhani, et al.
Peptide Science (2025) Vol. 117, Iss. 1
Closed Access
Pharmaceutical innovation and advanced biotechnology in the biotech-pharmaceutical industry for antibody–drug conjugate development
Qi Ma, Puro Durga, Frederick X.C. Wang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104057-104057
Closed Access | Times Cited: 4
Qi Ma, Puro Durga, Frederick X.C. Wang, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104057-104057
Closed Access | Times Cited: 4
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 4
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 4
Recent Advances in Photodynamic Therapy: Metal-Based Nanoparticles as Tools to Improve Cancer Therapy
Stefania Mariano, Elisabetta Carata, Lucio Calcagnile, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 932-932
Open Access | Times Cited: 2
Stefania Mariano, Elisabetta Carata, Lucio Calcagnile, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 932-932
Open Access | Times Cited: 2
CAR-T lymphocyte-based cell therapies; mechanistic substantiation, applications and biosafety enhancement with suicide genes: new opportunities to melt side effects
Paula Ercilla-Rodríguez, Marta Sánchez‐Díez, Nicolás Alegría‐Aravena, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Paula Ercilla-Rodríguez, Marta Sánchez‐Díez, Nicolás Alegría‐Aravena, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Next-Generation Immunotherapy: Advancing Clinical Applications in Cancer Treatment
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 2
Pankaj Kumar Garg, Siddhika Pareek, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6537-6537
Open Access | Times Cited: 2
<i>Mycobacterium smegmatis</i> enhances shikonin-induced immunogenic cell death—an efficient <i>in situ</i> tumor vaccine strategy
Zhaoye Qian, Zhe Zhang, Lanqi Cen, et al.
Journal of Biomedical Research (2024) Vol. 38, Iss. 4, pp. 369-369
Open Access | Times Cited: 1
Zhaoye Qian, Zhe Zhang, Lanqi Cen, et al.
Journal of Biomedical Research (2024) Vol. 38, Iss. 4, pp. 369-369
Open Access | Times Cited: 1
Synergistic Enhancement of Chemotherapy-Induced Cell Death and Antitumor Efficacy against Tumoral T-Cell Lymphoblasts by IMMUNEPOTENT CRP
Ana Luisa Rivera-Lazarín, Kenny Misael Calvillo‐Rodríguez, Mizael Izaguirre-Rodríguez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7938-7938
Open Access | Times Cited: 1
Ana Luisa Rivera-Lazarín, Kenny Misael Calvillo‐Rodríguez, Mizael Izaguirre-Rodríguez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7938-7938
Open Access | Times Cited: 1
The Role of Resveratrol in Cancer Management: From Monotherapy to Combination Regimens
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 4, pp. 307-326
Open Access | Times Cited: 1
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 4, pp. 307-326
Open Access | Times Cited: 1
Amplifying Curcumin’s Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment
Janviere Kabagwira, Ryan N. Fuller, Paul Vallejos, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 63-78
Open Access
Janviere Kabagwira, Ryan N. Fuller, Paul Vallejos, et al.
OncoTargets and Therapy (2024) Vol. Volume 17, pp. 63-78
Open Access
Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow
Manuel Beltrán‐Visiedo, Alfonso Serrano del Valle, Nelia Jiménez‐Alduán, et al.
Methods in cell biology (2024), pp. 189-206
Closed Access
Manuel Beltrán‐Visiedo, Alfonso Serrano del Valle, Nelia Jiménez‐Alduán, et al.
Methods in cell biology (2024), pp. 189-206
Closed Access
铱(III)光敏剂的设计与抗肿瘤研究进展
Qiaoshan Lie, Hui Chao
Scientia Sinica Chimica (2024) Vol. 54, Iss. 9, pp. 1522-1533
Open Access
Qiaoshan Lie, Hui Chao
Scientia Sinica Chimica (2024) Vol. 54, Iss. 9, pp. 1522-1533
Open Access
Nano-enabled regulation of DNA damage in tumor cells to enhance neoantigen-based pancreatic cancer immunotherapy
Jilong Wang, Chenghu Wu, Yiran Wang, et al.
Biomaterials (2024) Vol. 311, pp. 122710-122710
Closed Access
Jilong Wang, Chenghu Wu, Yiran Wang, et al.
Biomaterials (2024) Vol. 311, pp. 122710-122710
Closed Access
Use of drug-killed cancer cells: A method to assess the therapeutic effectiveness of immunogenic cell death
Kenny Misael Calvillo‐Rodríguez, Maria Norma Gonzalez-Flores, Reyes Taméz-Guerra, et al.
Methods in cell biology (2024), pp. 211-220
Closed Access
Kenny Misael Calvillo‐Rodríguez, Maria Norma Gonzalez-Flores, Reyes Taméz-Guerra, et al.
Methods in cell biology (2024), pp. 211-220
Closed Access
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy
Renhua Guo, Ping Wang
Breast Cancer (2024)
Closed Access
Renhua Guo, Ping Wang
Breast Cancer (2024)
Closed Access